Burning Rock Biotech BNR reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM.
Here's what investors need to know about the announcement.
Earnings
Burning Rock Biotech missed estimated earnings by 5.71%, reporting an EPS of $-0.37 versus an estimate of $-0.35.
Revenue was down $179 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 1.67% drop in the share price the next day.
Here's a look at Burning Rock Biotech's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.36 | -0.27 | -0.25 | -0.15 |
EPS Actual | -0.39 | -0.38 | -0.25 | -0.30 |
Revenue Estimate | 20.81M | 21.47M | 20.15M | 21.41M |
Revenue Actual | 21.38M | 23.12M | 19.65M | 19.71M |
To track all earnings releases for Burning Rock Biotech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.